| Followers | 1129 |
| Posts | 32324 |
| Boards Moderated | 1 |
| Alias Born | 01/11/2016 |
Thursday, March 21, 2024 8:47:12 PM
Recent LTRN News
- Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026 • Business Wire • 02/10/2026 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 12:31:05 PM
- Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas • Business Wire • 01/20/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:05:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:05:08 PM
- Lantern Pharma Announces Establishing an A.I. Center of Excellence in India to Industrialize the RADR® Platform and Accelerate Global Development Opportunities with BioPharma Companies • Business Wire • 01/12/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 09:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 09:05:24 PM
- Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials • Business Wire • 12/03/2025 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:30:56 PM
- Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates • Business Wire • 11/13/2025 01:30:00 PM
- Lantern Pharma to Spotlight AI Drug-Development Platforms at UNT’s First AI4BM Symposium • IH Market News • 11/13/2025 11:15:23 AM
- New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST • ACCESS Newswire • 11/08/2025 04:40:00 PM
- Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows • ACCESS Newswire • 11/07/2025 02:00:00 PM
- Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET • Business Wire • 11/06/2025 01:00:00 PM
- Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT • Business Wire • 10/30/2025 12:00:00 PM
- Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers. • Business Wire • 10/28/2025 12:49:00 PM
- Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025 • Business Wire • 10/24/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2025 08:45:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2025 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2025 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2025 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/23/2025 08:05:09 PM
- Lantern Pharma Shares Soar as LP-184 Cancer Drug Hits Key Trial Goals • IH Market News • 09/16/2025 02:21:46 PM
UPDATE: Hydromer, Inc. Announces Expansion Into High-Speed Automated Coating and UV Cure Equipment Manufacturing • HYDI • Feb 10, 2026 10:58 AM
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • MWAI • Feb 10, 2026 8:45 AM
LaFleur Minerals Reports Assay Results Highlighting 2.05 g/t Au over 158.25 metres, Confirming Strong Gold Continuity at Swanson Gold Project • LFLRF • Feb 5, 2026 5:29 AM
DRCR Begins Rollout of New Business Model • DRCR • Feb 4, 2026 12:42 PM
BIO-PATH HOLDINGS ANNOUNCES "BPTH 2.0" STRATEGIC PIVOT ON WORLD CANCER DAY; ENGAGES LEGAL COUNSEL FOR REGULATION A OFFERING • BPTH • Feb 4, 2026 10:00 AM
Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • BLEG • Feb 4, 2026 9:07 AM
